Categories: News

AVentures Capital Invests in Viseven, a Fast-Growing Digital Solution Provider for the Pharmaceutical and Life Sciences Enterprise Companies

AVentures Capital invested in Viseven, a fast-growing digital solution provider for the world�s largest pharmaceutical and life sciences players, and became a minority shareholder. Viseven provides full-cycle digital multichannel solutions for life sciences and pharmaceutical industries.

Kyiv, Ukraine, June 03, 2019 –(PR.com)– AVentures Capital invested in Viseven, a fast-growing digital solution provider for the world’s largest pharmaceutical and life sciences players, and became a minority shareholder.

Viseven provides full-cycle digital multichannel solutions for life sciences and pharmaceutical industries. With 10 years’? experience in interactive eDetailing services (digitization of sales content on a mobile device), the company addresses all aspects of the content lifecycle from concept and materials to smooth integration with the clients’ CRM system. Viseven also offers a powerful SaaS solution for content creation and management – eWizard platform, the only platform with automatic email publishing to Salesforce Marketing Cloud. Viseven is a global company with EU headquarters, functional offices in the USA and Canada, and delivery hub in Ukraine manages worldwide cooperation with market leaders such as Novo Nordisk, Biogen, Abbott, Bayer.

Nataliya Andreychuk, CEO and one of the co-founders of Viseven: “Over the years Viseven has continuously empowered its global customers with multichannel capabilities, reducing production costs and enabling them to deliver personalized content to the audience across the whole spectrum of channels with full cycle digital pharma solutions. We are set to continue rapid growth and invest in our staff and services and look forward to building a strong globally-known company together with our partners.”

“Viseven is one of the fastest growing vertically-focused digital businesses in CEE. We were impressed by the Viseven’s team, their energy and ambition to become a large global enterprise. Knowing the level of their expertise, I have no doubts about their potential to become a leading player in pharma vertical in enterprise segment globally,” said Yevgen Sysoyev, managing partner of AVentures Capital who joined Viseven Board as a Director.

AVentures Capital is a leading investment and M&A advisory firm that leverages R&D in Ukraine and CEE founded in 2012. The firm invests and provides M&A advisory services across IT outsourcing, software, e-commerce, cloud services, mobile technology, IoT and other sectors. AVentures Capital has over 15 companies in its portfolio that operate in the US and EU market and leverage R&D in Ukraine and CEE.

Let’s block ads! (Why?)

Miscw.com

Recent Posts

ROBAM Announces Breakthrough Dishwasher Technology, Poised to Lead in Industry

HANGZHOU, China--(BUSINESS WIRE)--#Dishwasher--ROBAM, the leader of premium kitchen appliances, is revolutionizing the industry with the…

1 hour ago

Eight leaders with diverse backgrounds elected to ISCA Council

SINGAPORE - Media OutReach Newswire - 27 April 2024 - A diverse group of eight…

1 day ago

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology

GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D., to serve as advisors to…

1 day ago

Juicy Stakes Casino Juice Up Their Soft Series

New $10 Takedown and Champions Tournament extend poker extravaganza SYDNEY--(BUSINESS WIRE)--April, May… it doesn’t matter…

1 day ago

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY

Well positioned to capitalize with its AI-led propositions, global delivery model and ideal mix of…

1 day ago